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EFFECT OF ISOFLAVONES ON THE VASCULAR ACTIONS OF 
PHOSPHODIESTERASE INHIBITORS 
 
Alison WS KWONG, Susan WS LEUNG and Ricky YK MAN 
Pharmacology & Pharmacy, University of Hong Kong, China 
 
Isoflavones are present in high concentrations in soy products, the intake of which is associated 
with lower incidence of cardiovascular diseases. They can enhance contraction and inhibit 
relaxation through cyclic adenosine monophosphate (cAMP)-dependent pathway. The present 
study aimed to examine whether or not the major soy isoflavones, genistein, daidzein and 
glycetein, interfere with the action of phosphodiesterase (PDE) inhibitors on the vasculature. 
Porcine coronary arteries were isolated and suspended in organ chambers for the measurement of 
isometric tension. Both rolipram (cAMP-selective PDE4 inhibitor) and zaprinast (cyclic 
guanosine monophosphate (cGMP)-selective PDE5 inhibitor) concentration-dependently relaxed 
porcine coronary artery rings that were contracted with U46619 (stable thromboxane A2 analogue, 
30 nM). L-NAME (nitric oxide synthase inhibitor, 300 μM), but not indomethacin 
(cyclooxygenase inhibitor, 10 μM), inhibited rolipram- and zaprinast-induced relaxations. 
Genistein (3 μM), daidzein (3 μM) and glycetein 10 μM) did not affect zaprinast-induced 
relaxations in the absence or presence of LNAME or indomethacin. Relaxations to rolipram were 
also not affected by genistein and daidzein, while glycetein significantly inhibited rolipram-
induced relaxation. This inhibitory effect of glycetein was not affected by L-NAME or 
indomethacin. The present findings suggest that the basal release of nitric oxide contributes 
significantly to rolipram- and zaprinast-induced relaxation. While genistein and daidzein do not 
affect the vascular actions of these PDE inhibitors, glycetein inhibits relaxation to rolipram 
through a pathway that is independent of nitric oxide synthase activity. 
